Wilmington Funds Management’s Integra LifeSciences IART Stock Holding History

Wilmington Funds Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$281K	Buy	+14,623	New	+$272K	0.03%	557

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wilmington Funds Management's IART Position: Q2 2014 in Review

Wilmington Funds Management opened a new position in Integra LifeSciences (IART) in Q2 2014: 14,623 shares worth $281K. The stake represents 0.03% of the portfolio and ranks #557 among its holdings.

147 funds tracked by Wall St. Rank hold IART as of Q2 2014.

Wilmington Funds Management held 14,623 shares of Integra LifeSciences worth $281K as of Q2 2014.
Integra LifeSciences was a new Wilmington Funds Management position in Q2 2014.
Integra LifeSciences made up 0.03% of Wilmington Funds Management's portfolio in Q2 2014, its #557 holding.
147 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.